PBDE: Structure-Activity Studies for the Inhibition of Hepatitis C Virus NS3 Helicase

Inhibition of Hepatitis C Virus NS3 Helicase by Manoalide

(2012) Kazi Abdus Salam et al.   JOURNAL OF NATURAL PRODUCTS

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

(2011) Marc G. Ghany et al.   HEPATOLOGY

Introduction: A smouldering public-health crisis

(2011) Lauren Gravitz   NATURE

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

(2011) Fred Poordad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

(2011) Bruce R. Bacon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telaprevir for Retreatment of HCV Infection

(2011) Stefan Zeuzem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

(2011) Ira M. Jacobson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Real-time monitoring of RNA helicase activity using fluorescence resonance energy transfer in vitro

(2010) Hidenori Tani et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Hepatitis C Virus Non-structural Protein 3 (HCV NS3): A Multifunctional Antiviral Target

(2010) Kevin D. Raney et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Development of novel antiviral therapies for hepatitis C virus

(2010) Kai Lin   VIROLOGICA SINICA